[Percutaneous alcohol injection of hepatic tumors using ultrasonic guidance: a new therapeutic approach].
Ultrasound guided percutaneous alcoholization of the liver has been carried out using a large volume of alcohol (usually 20 to 30 ml) with no adverse reaction and its efficacy was perceptible after about 6 sessions. The best results were achieved in hepatocarcinomas in a context of Child A cirrhosis (6 out 6 lesion became negative). In hepatocarcinoma in a context of Child B and C cirrhosis and in hepatic metastases, the outcome depends on the initial disorder.
Bastid
C
C
Hôpital Sainte-Marguerite, Marseille.
D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015552:Injections, Intralesional; D008103:Liver Cirrhosis / Q000150:complications / Q000503:physiopathology; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014463:Ultrasonography
D000431:Ethanol
L'alcoolisation percutanée des tumeurs hépatiques sous contrôle échographique: une nouvelle approche thérapeutique.